ImportRefusal LogoImportRefusal

Bristol Myers Squibb

⚠️ Moderate Risk

FEI: 3005583930 • Agen, Lot Et Garonne • FRANCE

FEI

FEI Number

3005583930

📍

Location

Agen, Lot Et Garonne

🇫🇷

Country

FRANCE
🏢

Address

304 avenue du Docteur Jean Bru, , Agen, Lot Et Garonne, France

Moderate Risk

FDA Import Risk Assessment

32.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
5
Unique Violations
5/23/2017
Latest Refusal
9/22/2008
Earliest Refusal

Score Breakdown

Violation Severity
55.6×40%
Refusal Volume
31.3×30%
Recency
0.0×20%
Frequency
6.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4725×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
5/23/2017
60LAL01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
472NO ENGLISH
Division of Northeast Imports (DNEI)
5/22/2017
61XAA21DOXYLAMINE SUCCINATE (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
472NO ENGLISH
Division of Northeast Imports (DNEI)
10/21/2016
62GCE99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
3/26/2014
60LBR01ACETAMINOPHEN (ANALGESIC)
472NO ENGLISH
Division of Northeast Imports (DNEI)
9/22/2008
60LAL01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
75UNAPPROVED
Chicago District Office (CHI-DO)
9/22/2008
60LAL01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
75UNAPPROVED
Chicago District Office (CHI-DO)

Frequently Asked Questions

What is Bristol Myers Squibb's FDA import refusal history?

Bristol Myers Squibb (FEI: 3005583930) has 6 FDA import refusal record(s) in our database, spanning from 9/22/2008 to 5/23/2017.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Bristol Myers Squibb's FEI number is 3005583930.

What types of violations has Bristol Myers Squibb received?

Bristol Myers Squibb has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Bristol Myers Squibb come from?

All FDA import refusal data for Bristol Myers Squibb is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.